7 results
Stroke and bleeding risk stratification with the CHADS2-VASc and HAS-BLED schemas

#Diagnosis #Hematology #CHADS2 #CHADS2VASc #HASBLED #Comparison
Stroke and bleeding ... #CHADS2 #CHADS2VASc ... #HASBLED #Comparison ... #Score #Risk #Stroke ... #Bleed #Anticoagulation
CHA2DS2VASc vs HAS-BLED scores for stroke risk and bleed risk on anticoagulation

C	Congestive Heart Failure	1

H	Hypertension	1

A2	Age >75	2

D	Diabetes Mellitus	1

S2	Stroke,
CHA2DS2VASc vs HAS-BLED ... risk and bleed ... risk on anticoagulation ... #Score #Risk #Stroke ... #Bleed #Anticoagulation
Bleeding risk calculators - HAS-BLED (atrial fibrillation) and IMPROVE (VTE prophylaxis for inpatients)
Important notes:
 • No
Bleeding risk calculators ... - HAS-BLED (atrial ... risk #HASBLED ... Calculators #Anticoagulation ... #Factors #Hematology
HAS-BLED Score - Risk of Major Bleeding in 1 Year
Characteristics (1 point each)
 • Hypertension: Baseline
HAS-BLED Score - ... Risk of Major Bleeding ... EricsMedicalLectures/ #HASBLED ... #Score #Risk #Bleeding ... #anticoagulation
HAS-BLED Score
 - Hypertension: Baseline SBP > 160mmHg
 - Renal disease: Cr > 2.6mg/dL, on HD,
HAS-BLED Score ... Eric Strong https ... DrEricStrong #HASBLED ... #Risk #Score #Bleeding ... #Anticoagulation
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Longterm Venous ... PE - High Bleeding ... - Not High Bleeding ... #management #hematology ... #anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
• Treatment algorithms ... appropriate only for low risk ... patients with no CV risk ... Hydroxyurea + anticoagulation ... (if history of venous